Clinical Trial Results
Showing:
All studies
[change]
Condition: Lupus
25 trials found
New Search
The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
RECRUITING
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
RECRUITING
A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
RECRUITING
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
RECRUITING
FT839 in Autoimmune Diseases
RECRUITING
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
RECRUITING
Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
RECRUITING
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
RECRUITING
A Study of Quinacrine in Participants With Cutaneous Lupus Erythematosus
RECRUITING
A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G
RECRUITING
Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus
RECRUITING
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
RECRUITING
Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders
RECRUITING
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
RECRUITING
A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
RECRUITING
A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)
RECRUITING
A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants
RECRUITING
2-HOBA in Systemic Lupus Erythematosus
RECRUITING
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
RECRUITING
Autologous Stem Cell Transplant (ASCT) for Autoimmune Diseases
RECRUITING
Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users
RECRUITING
A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132
RECRUITING
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
RECRUITING
Trial of Belimumab in Early Lupus
RECRUITING
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)
RECRUITING